Hims & Hers Health stock is trading at $25.43, down 2.15% over 24 hours, with Binance Futures order flow showing aggressive selling pressure and a neutral 8-hour funding rate. The tokeniz...
HIMS is trading at $25.43, near the lower end of its 24-hour range of $26.30 to $25.10, after a 2.15% decline. That puts price below the 7-day SMA at $25.62 and well under the 20-day and 50-day averages at $27.16 and $28.42, respectively. The setup matters because the tape is still capped beneath the near-term pivot at $25.61 and has not reclaimed the first resistance band at $26.12.
Daily RSI at 42.03 sits in neutral territory, but the broader momentum read is still weak: MACD is negative at -0.8898 and the histogram is flat at 0.0000, which points to a stalled trend rather than a clean rebound. Stochastic %K at 34.67 and %D at 27.73 also suggest price is closer to oversold than overbought, but not yet at an extreme that would force a reversal on its own.
The most important downside reference is immediate support at $24.92, followed by strong support at $24.41. Bollinger lower band support comes in at $24.21, which lines up closely with that lower-trend area and reinforces the idea that the market is testing the lower edge of its recent range. On the upside, HIMS needs to clear $26.12 first, then $26.81, before the 20-day average at $27.16 starts to matter as a recovery level.
0000%, so perpetual positioning is not being skewed by a heavy long premium or short premium.
Source link
